Nuclear Imaging in Metastatic Paraganglioma

Area of Science:

• Endocrinology
• Oncology
• Nuclear Medicine

Background:

• Paragangliomas associated with SDHD gene mutations can metastasize.
• Diagnosis of metastatic paraganglioma can be challenging due to variable imaging characteristics.

Observation:

• A case of metastatic paraganglioma with SDHD gene mutation presented negative findings on iodine-123 metaiodobenzylguanidine scintigraphy.
• The same tumor showed positive uptake on indium-111 labeled octreotide scintigraphy.

Findings:

• This discrepancy in nuclear avidity suggests that not all SDHD-mutated paragangliomas behave uniformly in diagnostic imaging.
• The positive octreotide scan indicates potential for targeted therapies.

Implications:

• This case suggests a potential for peptide receptor radionuclide therapy (PRRT) in managing metastatic paraganglioma.
• Further research into PRRT for specific paraganglioma subtypes is warranted.